Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Effecty vs Vytora Health

Vytora Health costs $10 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Effecty logo

Effecty

8.2
★★★★☆4.1/5

Best for: moving between compounded and brand without changing seller

Visit Effecty →
VS
Vytora Health logo

Vytora Health

8.3
★★★★☆4.2/5

Best for: moving between compounded and brand without changing seller

Visit Vytora Health →

If you are choosing between Effecty and Vytora Health, the first difference is cost: Vytora Health is $10 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Vytora Health leads our six-part score, 8.3 to 8.2.

Effecty vs Vytora Health price

Vytora Health is the cheaper way in: $150 a month against $160 a month at Effecty. That is $10 less each month (6% lower), or about $120 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Vytora Health ($150 a month vs $160 a month); tirzepatide is cheaper at Vytora Health ($200 a month vs $240 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format they match: each offers compounded injections and brand-name pens.

Where each one treats patients

Effecty lists 50 states, and Vytora Health lists 51 states.

They overlap in 50 states. Vytora Health alone covers District of Columbia.

Pricing

Effecty

Compounded GLP-1 (12-mo plan)Compounded
$160$60/mo
Save 63% right now
semaglutide

$60 first month, then $160/mo on the 12-month plan.

Compounded GLP-1 (1-mo)Compounded
$205$105/mo
Save 49% right now
semaglutide

$105 first month, then $205/mo.

Compounded GLP-1+GIP (tirzepatide-class, 12-mo plan)Compounded
$240$140/mo
Save 42% right now
tirzepatide

NEW tirzepatide-class dual-agonist line. $140 first month, then $240/mo on the 12-month plan.

Compounded GLP-1+GIP (tirzepatide-class, 1-mo)Compounded
$305$205/mo
Save 33% right now
tirzepatide

$205 first month, then $305/mo.

OzempicBrand-name
$1300/mo
semaglutide
WegovyBrand-name
$1600/mo
semaglutide
ZepboundBrand-name
$1400/mo
tirzepatide
MounjaroBrand-name
$1300/mo
tirzepatide

Vytora Health

All dosesCompounded
$180/mo
semaglutide
3-mo bundle ($450 billed)Compounded
$150/mo
semaglutide
All dosesCompounded
$249/mo
tirzepatide
3-mo bundle ($599 billed)Compounded
$200/mo
tirzepatide
Brand 5/7.5/10/12.5/15 mgBrand-name
$1399/mo
mounjaro
Brand 2.5/5/7.5/10/12.5/15 mgBrand-name
$1399/mo
zepbound

What each price covers

Both prices cover the clinician visit, the medication itself and shipping.

Effecty is silent on lab work and coaching.

Vytora Health is silent on lab work and coaching.

Effecty

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Vytora Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Vytora Health scores 8.3 and Effecty 8.2 out of 10.

Vytora Health is stronger on value (6.6 vs 6.0).

Effectiveness, user experience, trust & safety, accessibility and support are within half a point.

How we score

Effecty

8.2/10

Overall

Vytora Health

8.3/10

Value25%

6.0A
vs
B
6.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.5A
vs
B
8.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

FDA warning letters

Neither Effecty nor Vytora Health has an FDA warning letter on record with us.

Features & Coverage

FeatureEffectyVytora Health
Starting Price$160/mo✓$150/mo
Features7 features✓8 features
States Available50✓51
Compounded✓ Yes✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Effecty

Compounded GLP-1 injections cost $160-$205/mo at Effecty, which also carries the brand-name drugs Mounjaro, Zepbound, Wegovy and Ozempic. There are no membership fees, shipping reaches all states nationwide, and the platform is LegitScript certified.

Read our full Effecty review →

About Vytora Health

Semaglutide compounded runs $180/mo, or $150 if bought as a 3-month bundle; tirzepatide is $249/mo and $200 bundled the same way. Coverage takes in 50 states and DC. Brand-name Mounjaro and Zepbound are stocked too, along with the peptides NAD+ and sermorelin. Two pharmacy partners get named in public, Vials Pharmacy and Greenwich Biosciences, and the physician group behind the operation is disclosed, which few in this category do.

Read our full Vytora Health review →

Pros & Cons

Effecty

What we like

  • Semaglutide costs $160 a month, 14% below the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $240 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Effecty

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Vytora Health

What we like

  • Semaglutide costs $150 a month, 19% below the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $200 a month, 20% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Vytora Health

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Vytora Health

Vytora Health wins this one, 8.3 to 8.2, above all for moving between compounded and brand without changing seller. It also costs $10 less each month than Effecty. Effecty fits better if moving between compounded and brand without changing seller is your priority.

Choose Effecty if…

You want moving between compounded and brand without changing seller and an opening price near $160 a month.

Choose Vytora Health if…

You want moving between compounded and brand without changing seller and an opening price near $150 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.4

Strut Health

Semaglutide at $99/month, 48% below the typical price

8.4

Enhance MD

Knowing which pharmacy fills the vial: it names Tru Meds Rx

6.1

DudeMeds

Compounded semaglutide at $175/month

Effecty vs Vytora Health: FAQ

Vytora Health. It starts at $150 a month; Effecty starts at $160 a month, $10 more per month.
Yes, both sell semaglutide and tirzepatide.
Vytora Health: 51 states against 50, with 50 in common.
Both include the clinician visit, the medication itself and shipping.
Effecty has none. Vytora Health has none.
No. Neither Effecty nor Vytora Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.